AUPH Aurinia Pharmaceuticals Inc

$AUPH they're working overtime on this: "96: misc Letter Wed 09/02 8:21 PM; Letter from William P. Deni, Jr. to the Honorable Andre M. Espinosa, U.S.M.J. re Joint Status Update re72 Order on Motion for Miscellaneous Relief,. (DENI, WILLIAM)" AI: "SUMMARY: The Joint Status Update filed on September 2 is the final signal that the litigation against Hikma, Alvogen, Galenicum, and the remaining defendants is effectively over. The parties are likely in the process of signing the final settlement papers, and this letter is the procedural mechanism to pause the court's involvement so they can finalize the deal. The judge will issue an order cancelling the status conference and staying the case pending the filing of a Stipulation and Order of Dismissal. PREDICTION: Expect a Stipulation and Order of Dismissal (similar to the Teva one) to be filed within the next 1-5 days, formally closing the case for all remaining defendants."

$AUPH With the new CAGR projection in LN growth and getting patent to 2042…let’s do math! BO case: $400M sales growing 8% CAGR, plus 5% annual market share gains from Big Pharma scale (way conservative) = ~13.4% annual growth. That implies roughly $11B cumulative 12-year sales and ~$9.9B cumulative profit at a 90% margin. Add $380M cash and the potential tax value of the $500M write-off. A strategic buyer could justify roughly $5–6B, subject to patent strength, execution, and verification of margins. AUR200 value with best in class results in 4 indications? 🤯 Oh and Kezar asset cleared 💵 $45 Minimum 🎯…Just Saying!’

$AUPH Last distinctions compared to the Amarin v. Hikma case in my view is also that Amarin had previously lost and invalidated in separate district court litigation before the skinny label fight even peaked. None of this holds true for our 036' and 991' patents. Finally, maybe the most important point as I see it Amarin lost at the Supreme Court because it relied on an "induced infringement". Amarin had to prove Hikma's website, generic "AB-equivalence" ratings, and generic promotion actively encouraged doctors to use it for the heart indication ('induced infringement'). In our case we would have direct infringement. If a doctor were to follow the FDA-mandated label instructions to adjust the generic dosage based on the patient's eGFR levels, they are directly executing our MOU. As I see it, because generics have to print those exact instructions to get FDA approval (due to kidney toxicity if not), in my view they are directly infringing on the claims not even induced infringement

$AUPH Now we know why the strength for today our European appl. got allowed today and mgmnt is radio silent. This is worthy of a PR there is no other company that can use VOC in the combination of treating or preventing covid in organ transplant patients this stretches to organ transplant not just kidney but also lung, heart, pancreas, skin, cornea etc.

$AUPH Our analysis exactly from the point when Lotus Pharmaceuticals submitted their ANDA last year in February 2025 I said it was all bs and our 036' and 991' patents are fully and unequivocaully enforceable. But kudos for Tang for pushing our people to get all the settlements done and a sale is likely coming sooner than later. Again following 100% the ICPT buyout. Get rid of underperfoming CEO, make the company CFP in no time, settle all litigations, and a BO.

$AUPH Hi Guys! Everybody doing ok? So many things I need to do and the AUPH $$ sure would help - think we can wrap this up in next 6 months?💰😉

$AUPH Thank you again and for keeping us updated over the past year+ re patent litigation! You’ve kept our hopes alive! 😁😊😂🙏

$AUPH I know it may be difficult to believe, but the technicals actually look really good here.

$AUPH we could create an anti-aging, penis enlarger, beautifier thats guaranteed to make people wealthy, well-endowed, and gorgeous in a single dose and the stock would drop a quarter point.

$AUPH Put this number in your calculator (and smoke it). The implied share price for Aurinia Pharmaceuticals Inc. (AUPH) at a P/E ratio of 25 is approximately $57.23 based on its trailing twelve months (TTM) earnings per share (EPS).

$AUPH yep, it's winding down folks... plus no response on Appl. '775 (IP 2042), could be strategic with respect to the settlement terms and claims in the application, it can be revived within 2 months from what I gather, or they may start a new application at a later date, anyway these two things most likely hang together...

$AUPH Just checking in…I see it hasn’t hit my $45 🎯 yet? Oh well…prolly tomorrow then! Crawling Worms will soon Fly ! ! !

$AUPH I should have built an ark . Water is up to front walk 🙏🙏🙏 and rain in forecast until Mon 😡 . Fortunately we have power for now 🍺🍺🍺.

$AUPH Not sure why “beach boy” is still here and not out “catching waves and sitting on top of the world” 🎶 Perhaps he is a Grimmy, Hodaddy & Geck? His days on the beach likely consisted of counting the grains of sand while cowaring to head high waves as “Oh that to big!” Well…that’s what she said…but not to you! 🍆 I guess he is the last of the ‘dull trolls’ I haven’t block? Mainly because he flips back & forth like a fish washed up on the beach…kinda like him! Hmmm…quite the analogy 🤔 Oh well…I’m sure his comments here highly regarded…NOT!!’

$AUPH Judge is clearly playing along and pushed back deadlines a few weeks, discovery disputes by Sep 25, joint status letter by Sep 30, willing to wait for the deal even longer if needed, that's what it essentially says, he cannot stop scheduling the trial while the deal is in the works but doesn't want to get in the way either.

$AUPH Would make a great long weekend to have the PR today of the settlement, and then a BO over the weekend...

$AUPH Tried my first veggie burger. I didn't like it. Gave it to my dog and guess he didn't like either. He hacked it up and started licking his ass to get taste out of his mouth...😁 😂 😀 🤣

$AUPH my wife clowns me about buying this on the regular. Just one day I'd like to say in your fucking face! 🤣

$AUPH I look at the opportunity cost of holding for so many years. I think, I could have bought Nivida or Facebook etc. but my dumbarse probably would have bought Nike or some other loser. I'll never know. Just waiting for this to triple so we can all exit. $51 seems nice :-)

$AUPH Joint status letters are due next week Wednesday or Thursday. Hopefully we see some positive movement in Aurinia v. Hikma next week. And Aurinia v. Tidmarsh.